Skip to main content
DBD
NYSE Technology

10% Owner Millstreet Capital Sells $41.6M in Diebold Nixdorf Shares

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
7
Price
$84.98
Mkt Cap
$2.943B
52W Low
$53.1
52W High
$89.05
Market data snapshot near publication time

Summary

Millstreet Capital Management, a 10% owner, reported selling approximately $41.6 million worth of Diebold Nixdorf common shares in open market transactions between June 8 and June 25, 2026.


Key Events

  • Significant Share Sales

    Millstreet Capital Management, a 10% owner, sold 500,006 common shares for approximately $41.6 million through multiple open market transactions from June 8 to June 25, 2026.

  • Continued Stake Reduction

    Following these sales, Millstreet Capital Management's aggregate ownership stands at 4,204,432 shares, representing 12.14% of the outstanding common shares. This marks a continued reduction in their position.

  • Sales Near 52-Week High

    These sales occurred while Diebold Nixdorf's stock is trading near its 52-week high, potentially allowing the investor to lock in gains.


Analysis

This Schedule 13D/A filing details significant open market sales by Millstreet Capital Management, a major institutional investor. The sale of approximately $41.6 million worth of shares, representing over 1.4% of the company's market capitalization, indicates a continued reduction in their stake. While 10% owners often rebalance portfolios, the magnitude of these sales, especially following previous large sales, could be interpreted as a lack of conviction or a move to reduce exposure. The stock is currently trading near its 52-week high, which might be a factor in the timing of these sales.

At the time of this filing, DBD was trading at $84.98 on NYSE in the Technology sector, with a market capitalization of approximately $2.9B. The 52-week trading range was $53.10 to $89.05. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DBD - Latest Insights

DBD
Jun 26, 2026, 4:01 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $84.98
Real-time Price: $84.98 info
Change: $0 (0%) info
Market Cap: $2.943B info
DBD
Apr 30, 2026, 7:06 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $82.50
Real-time Price: $84.98 info
Change: +$2.48 (+3%) info
Market Cap: $2.943B info
DBD
Apr 17, 2026, 4:28 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $88.60
Real-time Price: $84.98 info
Change: -$3.62 (-4%) info
Market Cap: $2.943B info
DBD
Apr 10, 2026, 4:04 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $84.78
Real-time Price: $84.98 info
Change: +$0.200 (+0.24%) info
Market Cap: $2.943B info
DBD
Feb 12, 2026, 4:38 PM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $75.59
Real-time Price: $84.98 info
Change: +$9.39 (+12%) info
Market Cap: $2.943B info
DBD
Feb 12, 2026, 7:05 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $72.36
Real-time Price: $84.98 info
Change: +$12.62 (+17%) info
Market Cap: $2.943B info
DBD
Jan 20, 2026, 4:11 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $68.61
Real-time Price: $84.98 info
Change: +$16.37 (+24%) info
Market Cap: $2.943B info
DBD
Jan 20, 2026, 4:10 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $68.61
Real-time Price: $84.98 info
Change: +$16.37 (+24%) info
Market Cap: $2.943B info
DBD
Jan 15, 2026, 4:40 PM EST
Filing Type: 144
Importance Score:
7
Price at Filing: $69.91
Real-time Price: $84.98 info
Change: +$15.07 (+22%) info
Market Cap: $2.943B info